• Enterprise value to revenue forward of Galectin Therapeutics Inc. – NASDAQ:GALT TradingView Tue, 07 Jul 2026 17:17:08 GMT
• price to earnings forward of galectin therapeutics inc. – gettex:phpn TradingView Tue, 07 Jul 2026 00:15:11 GMT
• GALT jumps 11% on FDA alignment for belapectin phase III path in MASH MSN Sun, 05 Jul 2026 00:52:15 GMT
• if you invested $1,000 in galectin therapeutics inc (galt) Stock Titan Sat, 04 Jul 2026 01:27:22 GMT
• Form 4 Galectin Therapeutics Inc For: 30 June By Investing.com Investing.com Nigeria Wed, 01 Jul 2026 00:08:09 GMT
• Galectin Therapeutics director sells $150,890 in common stock By Investing.com Investing.com South Africa Tue, 30 Jun 2026 23:51:48 GMT
• Form 4 Galectin Therapeutics Inc For: 30 June By Investing.com Investing.com India Tue, 30 Jun 2026 23:37:18 GMT
• [Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Galectin Therapeutics CMO Jamil Khurram disposes of $262,083 in stock Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Galectin Therapeutics (GALT) CMO exits 52,037 shares in pre-planned sale Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Form 144 GALECTIN THERAPEUTICS INCORPORATED For: 29 June By Investing.com Investing.com UK Mon, 29 Jun 2026 22:32:00 GMT
• Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:30:59 GMT
• Harold Shlevin files Form 144: GALT (NASDAQ) sale of 7,732 shares Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Galectin Therapeutics Inc.(NasdaqCM: GALT) added to Russell 3000E Growth Benchmark marketscreener.com Mon, 29 Jun 2026 03:47:31 GMT
• Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• galectin therapeutics inc.(nasdaqcm: galt) added to russell 2500 index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• If you're not following me on stocktwits you probably should My money is on a partnership with Madrigal Moomoo Sun, 28 Jun 2026 06:34:00 GMT
• galt jumps 11% on fda alignment for belapectin phase iii path in mash MSN Sun, 28 Jun 2026 06:32:56 GMT
• galt stock surges 22% — on track for best day in over a year after fda clears path for late-stage belapectin trial MSN Sun, 28 Jun 2026 02:30:46 GMT
• galt stock surges 22% — on track for best day in over a year after fda clears path for late-stage belapectin trial MSN Sat, 27 Jun 2026 09:46:22 GMT
• galectin therapeutics inc (galt) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 27 Jun 2026 05:46:02 GMT
• form 144 galectin therapeutics inc for: 26 june by investing.com Investing.com Nigeria Sat, 27 Jun 2026 05:34:22 GMT
• form 144 galectin therapeutics incorporated for: 26 june by investing.com Investing.com South Africa Sat, 27 Jun 2026 01:35:37 GMT
• galectin therapeutics cmo jamil khurram sells $23,728 in shares by investing.com Investing.com Australia Sat, 27 Jun 2026 01:03:53 GMT
• Form 144 GALECTIN THERAPEUTICS INC For: 26 June By Investing.com Investing.com UK Fri, 26 Jun 2026 22:16:00 GMT
• Form 144 GALECTIN THERAPEUTICS INCORPORATED For: 26 June By Investing.com Investing.com Canada Fri, 26 Jun 2026 20:32:21 GMT
• galt stock surges 22% — on track for best day in over a year after fda clears path for late-stage belapectin trial MSN Fri, 26 Jun 2026 17:10:41 GMT
• GALT (NASDAQ: GALT) Rule 144 notice: Khurram Jamil reports share disposals Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• galectin therapeutics cmo jamil khurram sells $23,728 in shares Investing.com Fri, 26 Jun 2026 02:01:39 GMT
• Form 4 Galectin Therapeutics Inc For: 25 June By Investing.com Investing.com Nigeria Thu, 25 Jun 2026 22:54:26 GMT
• galt stock surges 22% — on track for best day in over a year after fda clears path for late-stage belapectin trial MSN Thu, 25 Jun 2026 21:41:30 GMT
• galectin therapeutics(galt) stock options chain | quotes & news Moomoo Thu, 25 Jun 2026 15:24:34 GMT
• galt jumps 11% on fda alignment for belapectin phase iii path in mash MSN Thu, 25 Jun 2026 10:45:12 GMT
• Galectin Therapeutics CMO Jamil Khurram sells $23,728 in shares Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• Galectin (NASDAQ: GALT) CMO exercises options and sells 7,557 shares under 10b5-1 plan Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• galectin therapeutics (galt) short interest & short float | updated jun 2026 $galt MarketBeat Thu, 25 Jun 2026 07:00:00 GMT
• fda alignment reduces risk for galectin therapeutics' belapectin phase 3 trial, keeping it a buy. Pluang Wed, 24 Jun 2026 18:43:16 GMT
• analysts offer insights on healthcare companies: galectin therapeutics (galt) and gilead sciences (gild) The Globe and Mail Wed, 24 Jun 2026 16:32:00 GMT
• GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside Seeking Alpha Wed, 24 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains galectin therapeutics(galt.us) with buy rating, maintains target price $11 Moomoo Wed, 24 Jun 2026 05:27:46 GMT
• Form 144 GALECTIN THERAPEUTICS INC For: 23 June By Investing.com Investing.com UK Wed, 24 Jun 2026 02:52:00 GMT
• galectin therapeutics (galt) announces fda agreement for phase 3 program GuruFocus Tue, 23 Jun 2026 20:10:59 GMT
• Galectin Therapeutics clears FDA Type C milestone, shares react on NASDAQ Ad-hoc-news.de Tue, 23 Jun 2026 17:54:09 GMT
• galt reiterated by hc wainwright & co. -- price target maintained at $11 GuruFocus Tue, 23 Jun 2026 17:44:57 GMT
• Galectin Therapeutics (GALT) Receives FDA Feedback for Phase 3 T GuruFocus Tue, 23 Jun 2026 16:58:38 GMT
• galectin therapeutics reaches alignment with fda on belapectin pathway TipRanks Tue, 23 Jun 2026 13:09:57 GMT
• Galectin Therapeutics Secures FDA Agreement for Phase 3 Belapectin Trial in MASH Cirrhosis and Portal Hypertension 1 Minichart Tue, 23 Jun 2026 12:44:00 GMT
• Galectin Advances Belapectin to Phase 3 After FDA Alignment TipRanks Tue, 23 Jun 2026 12:20:57 GMT
• Galectin Therapeutics stock surges on FDA trial agreement Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• Galectin Therapeutics Reaches FDA Agreement on Phase 3 Endpoint and Regulatory Path for Belapectin Full Approval Quiver Quantitative Tue, 23 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Galectin Therapeutics(GALT.US) With Buy Rating, Maintains Target Price $11 Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• GALT affiliate notifies sale of 8,125 shares (NASDAQ: GALT) Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Galectin reaches FDA agreement on Phase 3 trial for belapectin Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• Galectin Announces FDA Agreement on Phase 3 Endpoint and Q3 2026 Protocol Filing for Belapectin TradingView Tue, 23 Jun 2026 07:00:00 GMT
• Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hyp... The Manila Times Tue, 23 Jun 2026 07:00:00 GMT
• GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial Stocktwits Tue, 23 Jun 2026 07:00:00 GMT
• galectin therapeutics shares surge on positive fda meeting, phase 3 trial plans marketscreener.com Tue, 23 Jun 2026 07:00:00 GMT
• galectin therapeutics says fda alignment reached on phase 3 belapectin trial marketscreener.com Tue, 23 Jun 2026 07:00:00 GMT
• galecti, fda agree on phase 3 trial for mash drug (galt:nasdaq) Seeking Alpha Tue, 23 Jun 2026 07:00:00 GMT
• form 8k galectin therapeutics inc for: 23 june by investing.com Investing.com India Tue, 23 Jun 2026 07:00:00 GMT
• fda backs galectin (nasdaq: galt) belapectin phase 3 plan in mash Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• form 144 galectin therapeutics inc for: 23 june by investing.com Investing.com Canada Tue, 23 Jun 2026 07:00:00 GMT
• fda backs galectin’s belapectin program for liver disease Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• galt stock surges 22% - on track for best day in over a year after fda clears path for late-stage belapectin trial Mena FN Tue, 23 Jun 2026 06:30:31 GMT
• galt q1 2026 earnings: eps misses estimates by 30.72%; stock edges higher on pipeline progress - revenue beat analysis dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains galectin therapeutics(galt.us) with buy rating, maintains target price $11 富途牛牛 Fri, 19 Jun 2026 22:51:42 GMT
• galectin therapeutics inc (galt) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 03:05:01 GMT
• galectin therapeutics inc (galt) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 02:19:31 GMT
• galectin therapeutics inc (galt) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 02:17:21 GMT
• galectin therapeutics inc (galt) institutional confidence TradingKey Wed, 17 Jun 2026 17:54:32 GMT
• galectin therapeutics inc (galt) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 17:51:55 GMT
• galectin therapeutics inc (galt) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 17:27:50 GMT
• galectin therapeutics inc (galt) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 17:22:11 GMT
• galectin therapeutics inc (galt) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 17:19:28 GMT
• galectin therapeutics inc (galt) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:17:34 GMT
• Galectin Therapeutics (GALT) Slips 1.87% as Shares Consolidate Near Key Support - Value Factor dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• Galectin Therapeutics (GALT) Q1 2026 Earnings: EPS Misses Estimates as Pre‑Revenue Biotech Advances Pipeline dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• galectin therapeutics inc (galt) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• eliaz therapeutics launches reg cf raise to advance first device targeting sepsis GlobeNewswire Thu, 11 Jun 2026 07:00:00 GMT
• galt q1 2026 earnings: eps misses estimates as clinical-stage biotech faces investor scrutiny - earnings per share newsline.com Mon, 08 Jun 2026 07:00:00 GMT
• Glycobiology-driven therapeutic targeting of glycan-binding proteins: mechanisms, diseases, and clinical translation Nature Fri, 05 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains galectin therapeutics(galt.us) with buy rating, maintains target price $11 富途牛牛 Mon, 01 Jun 2026 09:43:10 GMT
• h.c. wainwright maintains galectin therapeutics(galt.us) with buy rating, maintains target price $11 富途牛牛 Thu, 28 May 2026 07:00:00 GMT
• galectin therapeutics cmo jamil khurram sells $1,761 in galt stock Investing.com Thu, 28 May 2026 07:00:00 GMT
• galectin therapeutics (galt) cmo sells 568 shares after option exercise Stock Titan Thu, 28 May 2026 07:00:00 GMT
• galectin therapeutics presents belapectin data at easl 2026 TipRanks Wed, 27 May 2026 16:11:48 GMT
• Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progr... Yahoo Finance Wed, 27 May 2026 07:00:00 GMT
• Galectin Therapeutics Q1 2026 Earnings: EPS Misses Estimates, Stock Rallies on Operational Progress - Cost Structure Review dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• GALT Q1 2026 Earnings: EPS Misses Estimates as Clinical Development Continues - Negative Surprise Momentum dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• galectin therapeutics (galt) unveils new insights from navigate trial at easl 2026 GuruFocus Wed, 27 May 2026 07:00:00 GMT
• galectin therapeutics (galt) holds near $2.50 after modest decline - percent above ma Newser Fri, 22 May 2026 20:30:25 GMT
• 12 health care stocks moving in friday's after-market session Benzinga Fri, 22 May 2026 07:00:00 GMT
• galt q1 2026 earnings: narrowed loss amid clinical progress, stock rally - guidance accuracy score The Legal Advocate Fri, 22 May 2026 06:30:22 GMT
• galectin therapeutics (galt) q1 2026 results miss estimates — eps $-0.08 vs $-0.06 - profit margin analysis newsline.com Tue, 19 May 2026 07:00:00 GMT
• galectin therapeutics (galt) stock: down -5.25%, support test at $1.98 2026-05-19 - stock analysis newsline.com Tue, 19 May 2026 07:00:00 GMT
• galectin therapeutics stock (us3631621074): biotech hopes focus on liver disease pipeline AD HOC NEWS Tue, 19 May 2026 07:00:00 GMT
• number of shareholders of galectin therapeutics inc. – nasdaq:galt TradingView Mon, 18 May 2026 23:05:45 GMT
• galectin therapeutics 1q research and development expenses $2.2m >galt Moomoo Sat, 16 May 2026 13:39:29 GMT
• galectin therapeutics q1 2026 financial report: earnings, balance sheet, and key disclosures Minichart Sat, 16 May 2026 07:00:00 GMT
• galectin therapeutics reports q1 2026 financial results and advances belapectin for mash cirrhosis with positive navigate trial da... Minichart Sat, 16 May 2026 07:00:00 GMT
• galectin therapeutics q1 2026 financial report: earnings, balance sheet, and key disclosures Minichart Fri, 15 May 2026 20:07:00 GMT
• galectin therapeutics reports q1 2026 financial results and advances belapectin for mash cirrhosis with positive navigate trial da... Minichart Fri, 15 May 2026 16:06:00 GMT
• galectin therapeutics releases q1 2026 financial results AlphaStreet Fri, 15 May 2026 13:54:02 GMT
• galectin therapeutics reports financial results for quarter ending march 31, 2026, and updates clinical programs geneonline.com Fri, 15 May 2026 12:38:30 GMT
• galectin therapeutics reports q1 2026 net loss of $5.1m, cash $14.1m; updates belapectin program TradingView Fri, 15 May 2026 11:53:00 GMT
• Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• h.c. wainwright maintains galectin therapeutics(galt.us) with buy rating, maintains target price $11 富途牛牛 Fri, 15 May 2026 07:00:00 GMT
• galectin therapeutics (nasdaq: galt) trims q1 2026 loss as r&d falls Stock Titan Fri, 15 May 2026 07:00:00 GMT
• galectin therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Fri, 15 May 2026 07:00:00 GMT
• belapectin reduces liver stiffness in high-risk mash cirrhosis trial Stock Titan Fri, 15 May 2026 07:00:00 GMT
• galectin therapeutics 1q 2026: financials not reported — 10-q summary TradingView Fri, 15 May 2026 07:00:00 GMT
• galectin therapeutics (nasdaq: galt) narrows q1 2026 loss but leans on large convertible debt Stock Titan Fri, 15 May 2026 07:00:00 GMT
• galectin therapeutics inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 07:00:00 GMT
• is galectin therapeutics (galt) fairly valued after q1 2026 earn GuruFocus Fri, 15 May 2026 07:00:00 GMT
• will galectin's new mash cirrhosis data renew stock momentum? RTTNews Tue, 12 May 2026 07:00:00 GMT
• galectin therapeutics (galt) highlights promising phase 2b trial results GuruFocus Tue, 12 May 2026 01:06:17 GMT
• galectin therapeutics (galt) highlights promising phase 2b trial results GuruFocus Mon, 11 May 2026 23:08:54 GMT
• galectin therapeutics publishes navigate phase 2b trial results TipRanks Mon, 11 May 2026 21:14:08 GMT
• galectin therapeutics inc expected to post a loss of 6 cents a share - earnings preview TradingView Mon, 11 May 2026 13:18:10 GMT
• galectin therapeutics announces publication of navigate phase 2b trial results for belapectin in the journal of hepatology Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• galectin publishes phase 2b trial results in hepatology Investing.com Mon, 11 May 2026 07:00:00 GMT
• galectin falls on mash candidate belapectin update, additional $10m credit line MSN Mon, 11 May 2026 05:55:23 GMT
• galectin falls on mash candidate belapectin update, additional $10m credit line MSN Sun, 10 May 2026 13:28:21 GMT
• why galectin therapeutics (galt) guidance matters more than actual results | q4 2025 newsline.com Fri, 08 May 2026 07:00:00 GMT
• galectin therapeutics to present new data on the treatment of fatty liver disease and fibrosis at aa Yahoo Sat, 02 May 2026 06:03:39 GMT
• galt stock price, quote & chart | galectin therapeutics inc (nasdaq:galt) ChartMill Fri, 01 May 2026 07:00:00 GMT
• galectin therapeutics to present new data on the treatment of fatty liver disease and fibrosis at aa Yahoo Tue, 28 Apr 2026 03:05:41 GMT
• Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm GlobeNewswire Mon, 27 Apr 2026 07:00:00 GMT
• galectin therapeutics (galt) upgraded to buy: what does it mean for the stock? msn.com Sun, 26 Apr 2026 22:14:38 GMT
• galectin therapeutics (galt) upgraded to buy: what does it mean for the stock? MSN Sat, 25 Apr 2026 14:11:41 GMT
• galt price today: galectin therapeutics inc. stock price, quote & chart | mexc MEXC Exchange Sat, 25 Apr 2026 08:54:30 GMT
• galt stock price, quote & chart | galectin therapeutics inc (nasdaq:galt) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• galectin therapeutics (galt) upgraded to buy: what does it mean for the stock? MSN Fri, 24 Apr 2026 00:15:41 GMT
• what are the key catalysts for galectin therapeutics (galt) stock (drifts higher) 2026-04-23 - eth profile The Legal Advocate Thu, 23 Apr 2026 07:00:00 GMT
• galt (galectin therapeutics inc.) q4 2025 narrower than expected loss drives 8.41 percent share gain amid positive investor sentim... Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 02:55:15 GMT
• galt (galectin therapeutics inc.) posts narrower q4 2025 loss than estimates, shares gain 3.64 percent on upbeat investor reaction... UBND thành phố Hải Phòng Wed, 22 Apr 2026 23:55:00 GMT
• université laval and glycovax pharma enter into an exclusive global license agreement for the development of innovative galectin-3... Yahoo Finance Wed, 22 Apr 2026 07:00:00 GMT
Galectin Therapeutics Inc(NASDAQ:GALT) 
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharid...
Website: http://galectintherapeutics.com
Founded: 2000
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology